Source: www.rwjf.org/publichealth Author: staff A preliminary analysis by the Food and Drug Administration (FDA) indicates that electronic cigarettes contain traces of toxic substances and carcinogens, contradicting manufacturers’ claims that the products are safe alternatives to tobacco, the New York Times reports. According to manufacturers, the battery-powered devices, which produce a vapor that users inhale, contain little more [...]
Continue reading...Thursday, July 1, 2010
Source: AACR Author: Staff WASHINGTON, D.C. — The American Association for Cancer Research recognizes the first anniversary of the Family Smoking Prevention and Tobacco Control Act, which was signed into law by President Obama on June 22, 2009. The law empowered the Food and Drug Administration (FDA) to regulate the marketing, advertising and manufacturing of tobacco products. Provisions [...]
Continue reading...Thursday, July 1, 2010
Source: The Swedish Match Author: Staff The Scandinavian snus market is comprised of a broad range of brands and product varieties, with pouch products being the most popular and continuing to grow in importance. The largest market in Scandinavia is Sweden, the largest snus market in the world measured in per capita consumption. Norway was the fastest [...]
Continue reading...Sunday, June 27, 2010
Source: news.yahoo.com Author: Marilynn Marchione, AP Medical Writer From long-term cancer risks to radiation overdose mistakes, CT scans pose a growing danger to the American public and need more regulation to improve their safety, imaging experts write in a leading medical journal. The articles in Thursday’s New England Journal of Medicine come a week after a [...]
Continue reading...Thursday, June 10, 2010
Source: NY Times Author: Walt Bogdanich GAITHERSBURG, Md. — Manufacturers of radiation therapy equipment said at a patient-safety conference here Wednesday that within the next two years their new equipment and the software that runs it would include fail-safe features to help reduce harmful radiation overdoses and other mistakes. The absence of these fail-safe features contributed to the fatal radiation [...]
Continue reading...Tuesday, March 9, 2010
Source: www.msmagazine.com Author: Adina Nack Jorge (not his real name) feared his girlfriend would dump him. He’d been diagnosed with genital warts before meeting her, and hadn’t yet told her about his infection. Jorge was being careful—no skin-to-skin sexual contact—but the disclosure was looming. So he’d done some research and learned what caused genital warts. Armed with [...]
Continue reading...Tuesday, February 9, 2010
Source: nytimes.com Authors: Walt Bogdanich & Rebecca R. Ruiz The federal Food and Drug Administration said Tuesday that it would take steps to more stringently regulate three of the most potent forms of medical radiation, including increasingly popular CT scans, some of which deliver the radiation equivalent of 400 chest X-rays. With the announcement, the F.D.A. puts its [...]
Continue reading...Saturday, December 19, 2009
Source: www.healthcanal.com Author: staff A minimally invasive surgical approach developed by head and neck surgeons at the University of Pennsylvania School of Medicine has been cleared by the U.S. Food and Drug Administration (FDA). The da Vinci Surgical System (Intuitive Surgical, Inc., Sunnyvale, California) has been cleared for TransOral Otolaryngology surgical procedures to treat benign tumors and [...]
Continue reading...Friday, October 30, 2009
Source: St. Petersburg Times Author: John Barry David Hastings’ crusade to inoculate boys against a cancer-causing virus that afflicts women — but threatened him, too — has scored a victory. But it’s not quite the one he has been fighting for in the past three years. A panel of the Centers for Disease Control and Prevention last week [...]
Continue reading...Sunday, September 27, 2009
Source: www.bloomberg.com Author: Lisa Rapaport Eli Lilly & Co.’s tumor-fighter Erbitux doesn’t prolong lung cancer patients’ lives enough to justify its $80,000 cost, U.S. scientists said in commentary published today. Erbitux added to other cancer drugs extends survival about 1.2 months more than chemotherapy alone, making the price too high for a “marginal benefit,” commentary in the Journal [...]
Continue reading...
Tuesday, July 20, 2010
0 Comments